No Data
No Data
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Stock Catapults 81% Though Its Price And Business Still Lag The Industry
Earnings Preview: AMLX to Report Financial Results Pre-market on November 07
Amylyx Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024
BofA Securities Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating
Perceptive Advisors LLC's Strategic Acquisition in Amylyx Pharmaceuticals Inc
Amylyx Upgraded to Buy by BofA on Hypoglycemia Drug Potential